No Data
No Data
H.C. Wainwright Maintains Metagenomi Technologies, LLC(MGX.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright analyst Mitchell Kapoor maintains $Metagenomi Technologies, LLC(MGX.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
HC Wainwright & Co. : The Metagenomi (MGX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.
HC Wainwright & Co. : The Metagenomi (MGX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.
HC Wainwright & Co. Reiterates Buy on Metagenomi, Maintains $10 Price Target
Metagenomi Q1 2024 Adj EPS $(1.19) Misses $(0.78) Estimate
Metagenomi Technologies, LLC | 10-Q: Quarterly report
No Data